On behalf of Vertex Pharmaceuticals, you are warmly invited to attend the first in a series of webinars devoted to Vertex-approved medicines, discussing the science behind CFTR modulator therapies in patients with cystic fibrosis.

"I agree to receive marketing e-mails and other promotional communications from Vertex Pharmaceuticals (Europe) Ltd and third parties acting on behalf of Vertex with product and disease information, invitations to events and information on approved Vertex products."

When sending you marketing emails, we use technologies to track our interactions with you, such as whether you receive and open our emails and whether you click on any links provided. This helps us measure and improve the relevance of our communications and strategies for you, as well as recipients more generally, and improve your online experience. By agreeing to receive emails from us you are agreeing to the use of such technologies.

You have a right to withdraw your consent at any time by clicking the unsubscribe link at the bottom of each communication. For more information relating to our privacy practices, including our use of cookies and similar technologies, please review our Privacy statement. https://global.vrtx.com/international-privacy

For more information about the meeting please refer to your meeting invitation or contact your local Medison representative. Medison is the acting distributor company in CEE markets on behalf of Vertex Pharmaceuticals.

Licensed Vertex medicines will be discussed at this meeting. Prescribing Information will be available at this meeting. This meeting is organised and fully funded by Vertex. This meeting is for Healthcare Professionals in Bulgaria, Croatia, Hungary, Romania, Slovenia and Poland.